TerrAscend (TSNDF) Cash & Equivalents (2021 - 2026)
TerrAscend's (TSNDF) quarterly Cash & Equivalents came in at $110000.0 in Q1 2026, down 99.62% year-on-year from $29.2 million in Q1 2025, and little changed on a QoQ basis from $110000.0 in Q4 2025.
TerrAscend (TSNDF) Cash & Equivalents (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Cash & Equivalents data on file, last reported at $110000.0 in Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 99.62% year-over-year to $110000.0 in Q1 2026; TTM through Mar 2026 was $110000.0, a 99.62% decrease from a year earlier, with the FY2025 full-year figure at $110000.0, down 81.85% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $110000.0, roughly flat from $110000.0 in the prior quarter.
- Over the last five years, Cash & Equivalents for TSNDF reached as high as $88.4 million in Q1 2022 and fell as low as $110000.0 in Q4 2025.
- Historically, Cash & Equivalents has averaged $19.3 million across 5 years, with a median of $22.2 million in 2023.
- Across the five-year window, Cash & Equivalents surged 4679.34% in 2023 and plunged 99.62% in 2026, its largest moves.
- Year by year, Cash & Equivalents stood at $26.2 million in 2022, then decreased by 14.97% to $22.2 million in 2023, then slumped by 97.28% to $606000.0 in 2024, then slumped by 81.85% to $110000.0 in 2025, then changed by 0.0% to $110000.0 in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $110000.0 in Q1 2026, $110000.0 in Q4 2025, and $36.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.76 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.79 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.28 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 266.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 428.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 110,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110,000.00 |
| Dec 31, 2025 | 110,000.00 |
| Sep 30, 2025 | 36.52 Mn |
| Jun 30, 2025 | 26.67 Mn |
| Mar 31, 2025 | 29.25 Mn |
| Dec 31, 2024 | 606,000.00 |
| Sep 30, 2024 | 26.64 Mn |
| Jun 30, 2024 | 3.11 Mn |
| Mar 31, 2024 | 3.11 Mn |
| Dec 31, 2023 | 22.24 Mn |
| Sep 30, 2023 | 606,000.00 |
| Jun 30, 2023 | 28.92 Mn |
| Mar 31, 2023 | 606,000.00 |
| Dec 31, 2022 | 26.16 Mn |
| Sep 30, 2022 | 34.29 Mn |
| Jun 30, 2022 | 605,000.00 |
| Mar 31, 2022 | 88.41 Mn |
| Dec 31, 2021 | 79.64 Mn |